Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Biological Chemistry
|
November 19, 2004
Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells
Jan van Riggelen, Gilles Buchwalter, Ubaldo Soto, et al.
Leukemia
|
May 4, 2018
FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome
Tianxiang Hu, Qing Wu, Yating Chong, et al.
Oncotarget
|
November 5, 2017
DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma
Candace J Poole, Wenli Zheng, Atul Lodh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 5, 2011
Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction
Peter S Choi, Jan van Riggelen, Andrew J Gentles, et al.
Oncotarget
|
March 19, 2015
p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia
Alper Yetil, Benedict Anchang, Arvin M Gouw, et al.
Genes & Development
|
June 17, 2010
The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance
Jan van Riggelen, Judith Müller, Tobias Otto, et al.
Cell Cycle (Georgetown, Tex.)
|
December 4, 2010
TGFβ-dependent gene expression shows that senescence correlates with abortive differentiation along several lineages in Myc-induced lymphomas
Judith Müller, Birgit Samans, Jan van Riggelen, et al.
Lab on a Chip
|
May 9, 2012
High throughput automated chromatin immunoprecipitation as a platform for drug screening and antibody validation
Angela R Wu, Tiara L A Kawahara, Nicole A Rapicavoli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 2006
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch
Sylvie Giuriato, Sandra Ryeom, Alice C Fan, et al.
Cell Discovery
|
February 1, 2019
Indispensable role of the Ubiquitin-fold modifier 1-specific E3 ligase in maintaining intestinal homeostasis and controlling gut inflammation
Yafei Cai, Guangxun Zhu, Siyang Liu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
The Journal of Biological Chemistry
|
November 19, 2004
Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells
Jan van Riggelen, Gilles Buchwalter, Ubaldo Soto, et al.
Leukemia
|
May 4, 2018
FGFR1 fusion kinase regulation of MYC expression drives development of stem cell leukemia/lymphoma syndrome
Tianxiang Hu, Qing Wu, Yating Chong, et al.
Oncotarget
|
November 5, 2017
DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma
Candace J Poole, Wenli Zheng, Atul Lodh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 5, 2011
Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction
Peter S Choi, Jan van Riggelen, Andrew J Gentles, et al.
Oncotarget
|
March 19, 2015
p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia
Alper Yetil, Benedict Anchang, Arvin M Gouw, et al.
Genes & Development
|
June 17, 2010
The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance
Jan van Riggelen, Judith Müller, Tobias Otto, et al.
Cell Cycle (Georgetown, Tex.)
|
December 4, 2010
TGFβ-dependent gene expression shows that senescence correlates with abortive differentiation along several lineages in Myc-induced lymphomas
Judith Müller, Birgit Samans, Jan van Riggelen, et al.
Lab on a Chip
|
May 9, 2012
High throughput automated chromatin immunoprecipitation as a platform for drug screening and antibody validation
Angela R Wu, Tiara L A Kawahara, Nicole A Rapicavoli, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 24, 2006
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch
Sylvie Giuriato, Sandra Ryeom, Alice C Fan, et al.
Cell Discovery
|
February 1, 2019
Indispensable role of the Ubiquitin-fold modifier 1-specific E3 ligase in maintaining intestinal homeostasis and controlling gut inflammation
Yafei Cai, Guangxun Zhu, Siyang Liu, et al.
Page
of 2